|
|
|
Volumn 23, Issue 4, 1996, Pages 506-528
|
|
New treatments for breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTIGESTAGEN;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EDATREXATE;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FADROZOLE;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
FORMESTANE;
GONADORELIN AGONIST;
GRANULOCYTE COLONY STIMULATING FACTOR;
GYRASE INHIBITOR;
IRINOTECAN;
LETROZOLE;
LIPOSOME;
LOSOXANTRONE;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
NAVELBINE;
OXANTHRAZOLE;
PACLITAXEL;
TOPOTECAN;
TRIMETREXATE;
UNINDEXED DRUG;
VOROZOLE;
ALOPECIA;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG FORMULATION;
FLUID RETENTION;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
MITOSIS SPINDLE;
MUCOSA INFLAMMATION;
ONCOGENE NEU;
PERIPHERAL NEUROPATHY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BIOLOGICAL RESPONSE MODIFIERS;
BREAST NEOPLASMS;
DRUG CARRIERS;
FEMALE;
GROWTH SUBSTANCES;
HUMANS;
LIPOSOMES;
PALLIATIVE CARE;
|
|
EID: 0029845811
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (39)
|
|
References (0)
|
